Israel’s Teva is to work with Intel Corp. to develop a wearable device combined with a machine learning platform to try and improve treatment for Huntington’s disease.  A smartwatch and smartphone will continuously measure the severity of the motoric symptoms.

http://www.timesofisrael.com/teva-intel-join-forces-to-monitor-huntington-disease/